Related references
Note: Only part of the references are listed.Protein structure predictions to atomic accuracy with AlphaFold
John Jumper et al.
NATURE METHODS (2022)
Ensembl 2022
Fiona Cunningham et al.
NUCLEIC ACIDS RESEARCH (2022)
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis
Andre D. J. Mckenzie et al.
ACS CHEMICAL NEUROSCIENCE (2022)
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
Ankit Verma et al.
MOLECULAR THERAPY (2022)
Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?
Elijah Genetzakis et al.
PHARMACOLOGY & THERAPEUTICS (2022)
P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease
Brandon G. Shokoples et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?
Paulo A. F. Pacheco et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Zeyi Huang et al.
CURRENT DRUG TARGETS (2021)
P2X7 receptor: a critical regulator and potential target for breast cancer
Xiaodi Zhu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?
Brendan Le Dare et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor
Henrique Inhauser Riceti Magalhaes et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Matthew Drill et al.
PURINERGIC SIGNALLING (2021)
Editorial: P2X7 as Common Therapeutic Target in Brain Diseases
Tobias Engel et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases
Abtar Mishra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy
Matteo Tassetto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia
Anna Pegoraro et al.
PURINERGIC SIGNALLING (2021)
P2X7 receptor acts as an efficient drug target in regulating bone metabolism system
Yutong Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial
Kasper Recourt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
Abraham J. Cisneros-Mejorado et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Qianqian Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
The P2X7 receptor: a new therapeutic target in Alzheimer's disease
Peter Illes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
P2X7 receptor: A potential therapeutic target for autoimmune diseases
Fan Cao et al.
AUTOIMMUNITY REVIEWS (2019)
P2X7 purinoceptor as a therapeutic target in muscular dystrophies
Dariusz C. Gorecki
CURRENT OPINION IN PHARMACOLOGY (2019)
Novel biologics targeting the P2X7 ion channel
Friedrich Koch-Nolte et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Targeting P2X4 and P2X7 receptors in multiple sclerosis
Maria Domercq et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
Alanna E. McCarthy et al.
CELL (2019)
P2X7, a critical regulator and potential target for bone and joint diseases
Dehui Zeng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2018)
The P2X7 receptor: A main player in inflammation
Elena Adinolfi et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases
Zhe Chen et al.
CLINICA CHIMICA ACTA (2018)
ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics
Linyu Wei et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
FRONTIERS IN PHARMACOLOGY (2018)
P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?
Chris N. J. Young et al.
FRONTIERS IN CHEMISTRY (2018)
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Jan M. Deussing et al.
TRENDS IN MOLECULAR MEDICINE (2018)
P2X7 receptor antagonists: a patent review (2010-2015)
Jin-Hee Park et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data
Laura Clarke et al.
NUCLEIC ACIDS RESEARCH (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
P2X7 receptor antagonism in amyotrophic lateral sclerosis
Ronald Sluyter et al.
NEURAL REGENERATION RESEARCH (2017)
The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition
Akira Karasawa et al.
ELIFE (2017)
The evolution of P2X7 antagonists with a focus on CNS indications
Jason C. Rech et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Welbeck Danquah et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa et al.
ELIFE (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel
Olivier Delaneau et al.
NATURE COMMUNICATIONS (2014)
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Rachael Bartlett et al.
PHARMACOLOGICAL REVIEWS (2014)
The 1000 Genomes Project: data management and community access
Laura Clarke et al.
NATURE METHODS (2012)
Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates
Alberto Baroja-Mazo et al.
JOURNAL OF OSTEOPOROSIS (2012)
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
Nishkantha Arulkumaran et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1β secretion
Leanne Stokes et al.
FASEB JOURNAL (2010)
Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway
Sandra Hubert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site
Sahil Adriouch et al.
FASEB JOURNAL (2008)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
P2X receptors as cell-surface ATP sensors in health and disease
Baljit S. Khakh et al.
NATURE (2006)
BLAST: improvements for better sequence analysis
Jian Ye et al.
NUCLEIC ACIDS RESEARCH (2006)
A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization
Ying-Hong Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The P2X7 receptor:: A key player in IL-1 processing and release
Davide Ferrari et al.
JOURNAL OF IMMUNOLOGY (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Pathophysiology and therapeutic potential of purinergic signaling
G Burnstock
PHARMACOLOGICAL REVIEWS (2006)
A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages
AN Shemon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP:: A role for P2X7 receptors
F Aswad et al.
JOURNAL OF IMMUNOLOGY (2005)
A role for mitogen-activated protein kinaseErk1/2 activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death
R Auger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes
G Cabrini et al.
JOURNAL OF IMMUNOLOGY (2005)
A 5′intronic splice site polymorphism leads to a nulll allele of the P2X7 gene in 1-2% of the Caucasian population
KK Skarratt et al.
FEBS LETTERS (2005)
Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1β release from human monocytes
R Sluyter et al.
JOURNAL OF IMMUNOLOGY (2004)
Molecular properties of ATP-gated P2X receptor ion channels
C Vial et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor
BJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules
ER Lazarowski et al.
MOLECULAR PHARMACOLOGY (2003)
Essential role for Ca2+ in regulation of IL-1β secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells
L Gudipaty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Genescript: DNA sequence annotation pipeline
AK Hudek et al.
BIOINFORMATICS (2003)
An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor
JS Wiley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region
ML Smart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alerting and tuning the immune response by extracellular nucleotides
A la Sala et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X7-dependent process inducing bacterial death by phagosome-lysosome fusion
IP Fairbairn et al.
JOURNAL OF IMMUNOLOGY (2001)
A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor
BJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
F Di Virgilio et al.
BLOOD (2001)
Altered cytokine production in mice lacking P2X7 receptors
M Solle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Extracellular metabolism of ATP and other nucleotides
H Zimmermann
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood
DG Perregaux et al.
JOURNAL OF IMMUNOLOGY (2000)
T-Coffee: A novel method for fast and accurate multiple sequence alignment
C Notredame et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
